IFF.N Hits 20-Day High Amid Investment Surge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 21 Nov 25
Source: Coinmarketcap
Shares of IFF.N reached a 20-day high today, reflecting a positive shift in investor sentiment. This technical breakout signals potential bullish momentum as the stock gains traction following a challenging year. Notably, Carl Icahn's family office has increased its investment in International Flavors & Fragrances by 27%, indicating confidence in a recovery for the stock. The broader market context includes significant moves by ultra-wealthy private investment firms, which have been capitalizing on AI-driven gains and shifting their focus towards consumer stocks, further bolstering IFF's appeal.
Analyst Views on IFF
Wall Street analysts forecast IFF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IFF is 80.66 USD with a low forecast of 68.00 USD and a high forecast of 89.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
6 Buy
3 Hold
0 Sell
Moderate Buy
Current: 72.160
Low
68.00
Averages
80.66
High
89.00
Current: 72.160
Low
68.00
Averages
80.66
High
89.00
About IFF
International Flavors & Fragrances Inc. is a creator and manufacturer of food, beverage, health and biosciences, scent, and complementary adjacent products. The Company's segment includes Taste, Food Ingredients, Health & Biosciences, and Scent. The Taste segment consists of a range of flavor compounds and natural taste solutions used in food and beverage applications. The Food Ingredients segment includes a broad portfolio of natural and plant-based specialty ingredients that provide texturizing and food protection capabilities, as well as soy and pea protein solutions, emulsifiers, and sweeteners. Its Health & Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. Its Scent segment creates fragrance compounds and fragrance ingredients that are integral elements in perfumes and household and personal care products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
